Year |
Citation |
Score |
2023 |
Achom M, Sadagopan A, Bao C, McBride F, Xu Q, Konda P, Tourdot RW, Li J, Nakhoul M, Gallant DS, Ahmed UA, O'Toole J, Freeman D, Lee GM, Hecht JL, ... ... Viswanathan SR, et al. A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma. Biorxiv : the Preprint Server For Biology. PMID 37577497 DOI: 10.1101/2023.08.04.552029 |
0.75 |
|
2023 |
Saad E, Saliby RM, Labaki C, Xu W, Viswanathan SR, Braun DA, Bakouny Z. Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes. Hematology/Oncology Clinics of North America. PMID 37391289 DOI: 10.1016/j.hoc.2023.05.023 |
0.311 |
|
2022 |
Sadagopan A, Nasim IT, Li J, Achom M, Zhang CZ, Viswanathan SR. Somatic XIST activation and features of X chromosome inactivation in male human cancers. Cell Systems. 13: 932-944.e5. PMID 36356577 DOI: 10.1016/j.cels.2022.10.002 |
0.737 |
|
2022 |
Konda P, Viswanathan SR. How splicing confers treatment resistance in prostate cancer. Elife. 11. PMID 35998026 DOI: 10.7554/eLife.82070 |
0.318 |
|
2022 |
Zhou M, Ko M, Hoge AC, Luu K, Liu Y, Russell ML, Hannon WW, Zhang Z, Carrot-Zhang J, Beroukhim R, Van Allen EM, Choudhury AD, Nelson PS, Freedman M, Taplin ME, ... ... Viswanathan SR, et al. Patterns of structural variation define prostate cancer across disease states. Jci Insight. PMID 35943799 DOI: 10.1172/jci.insight.161370 |
0.65 |
|
2022 |
Tang S, Sethunath V, Metaferia NY, Nogueira MF, Gallant DS, Garner ER, Lairson LA, Penney CM, Li J, Gelbard MK, Alaiwi SA, Seo JH, Hwang JH, Strathdee CA, Baca SC, ... ... Viswanathan SR, et al. A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer. Cell Reports. 38: 110417. PMID 35196489 DOI: 10.1016/j.celrep.2022.110417 |
0.595 |
|
2022 |
Bakouny Z, Sadagopan A, Ravi P, Metaferia NY, Li J, AbuHammad S, Tang S, Denize T, Garner ER, Gao X, Braun DA, Hirsch L, Steinharter JA, Bouchard G, Walton E, ... ... Viswanathan SR, et al. Integrative clinical and molecular characterization of translocation renal cell carcinoma. Cell Reports. 38: 110190. PMID 34986355 DOI: 10.1016/j.celrep.2021.110190 |
0.564 |
|
2021 |
Alesi N, Akl EW, Khabibullin D, Liu HJ, Nidhiry AS, Garner ER, Filippakis H, Lam HC, Shi W, Viswanathan SR, Morroni M, Ferguson SM, Henske EP. TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism. Nature Communications. 12: 4245. PMID 34253722 DOI: 10.1038/s41467-021-24499-6 |
0.727 |
|
2021 |
Bakouny Z, Braun DA, Shukla SA, Pan W, Gao X, Hou Y, Flaifel A, Tang S, Bosma-Moody A, He MX, Vokes N, Nyman J, Xie W, Nassar AH, Abou Alaiwi S, ... ... Viswanathan SR, et al. Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma. Nature Communications. 12: 808. PMID 33547292 DOI: 10.1038/s41467-021-21068-9 |
0.691 |
|
2020 |
Pomerantz MM, Qiu X, Zhu Y, Takeda DY, Pan W, Baca SC, Gusev A, Korthauer KD, Severson TM, Ha G, Viswanathan SR, Seo JH, Nguyen HM, Zhang B, Pasaniuc B, et al. Prostate cancer reactivates developmental epigenomic programs during metastatic progression. Nature Genetics. PMID 32690948 DOI: 10.1038/S41588-020-0664-8 |
0.433 |
|
2018 |
Viswanathan SR, Nogueira MF, Buss CG, Krill-Burger JM, Wawer MJ, Malolepsza E, Berger AC, Choi PS, Shih J, Taylor AM, Tanenbaum B, Pedamallu CS, Cherniack AD, Tamayo P, Strathdee CA, et al. Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer. Nature Genetics. PMID 29955178 DOI: 10.1038/S41588-018-0155-3 |
0.569 |
|
2018 |
Viswanathan SR, Ha G, Hoff AM, Wala JA, Carrot-Zhang J, Whelan CW, Haradhvala NJ, Freeman SS, Reed SC, Rhoades J, Polak P, Cipicchio M, Wankowicz SA, Wong A, Kamath T, et al. Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing. Cell. PMID 29909985 DOI: 10.1016/J.Cell.2018.05.036 |
0.682 |
|
2017 |
Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ, Viswanathan SR, Chattopadhyay S, Tamayo P, Yang WS, Rees MG, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. PMID 28678785 DOI: 10.1038/Nature23007 |
0.389 |
|
2015 |
Tu HC, Schwitalla S, Qian Z, LaPier GS, Yermalovich A, Ku YC, Chen SC, Viswanathan SR, Zhu H, Nishihara R, Inamura K, Kim SA, Morikawa T, Mima K, Sukawa Y, et al. LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans. Genes & Development. 29: 1074-86. PMID 25956904 DOI: 10.1101/Gad.256693.114 |
0.531 |
|
2015 |
Tu H, Schwitalla S, Qian Z, LaPier G, Yermalovich A, Ku Y, Chen S, Viswanathan SR, Zhu H, Nishihara R, Inamura K, Kim SA, Morikawa R, Mima K, sukawa Y, et al. Abstract 2300: LIN28 cooperates with Wnt signaling to drive invasive intestinal and colorectal adenocarcinoma in mouse and human Cancer Research. 75: 2300-2300. DOI: 10.1158/1538-7445.Am2015-2300 |
0.542 |
|
2014 |
Schwitalla S, Tu H, Viswanathan S, Zhu H, Qian Z, Shah S, Ogino S, Daley GQ. Abstract 2975: The pluripotency factor LIN28 promotes colorectal tumorigenesis and tumor progression Cancer Research. 74: 2975-2975. DOI: 10.1158/1538-7445.Am2014-2975 |
0.559 |
|
2010 |
Zhu H, Shah S, Shyh-Chang N, Shinoda G, Einhorn WS, Viswanathan SR, Takeuchi A, Grasemann C, Rinn JL, Lopez MF, Hirschhorn JN, Palmert MR, Daley GQ. Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies. Nature Genetics. 42: 626-30. PMID 20512147 DOI: 10.1038/Ng.593 |
0.508 |
|
2010 |
Viswanathan SR, Daley GQ. Lin28: A microRNA regulator with a macro role. Cell. 140: 445-9. PMID 20178735 DOI: 10.1016/J.Cell.2010.02.007 |
0.463 |
|
2009 |
Viswanathan SR, Mermel CH, Lu J, Lu CW, Golub TR, Daley GQ. microRNA expression during trophectoderm specification. Plos One. 4: e6143. PMID 19582159 DOI: 10.1371/Journal.Pone.0006143 |
0.486 |
|
2009 |
West JA, Viswanathan SR, Yabuuchi A, Cunniff K, Takeuchi A, Park IH, Sero JE, Zhu H, Perez-Atayde A, Frazier AL, Surani MA, Daley GQ. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature. 460: 909-13. PMID 19578360 DOI: 10.1038/Nature08210 |
0.535 |
|
2009 |
Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, O'Sullivan M, Lu J, Phillips LA, Lockhart VL, Shah SP, Tanwar PS, Mermel CH, Beroukhim R, Azam M, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nature Genetics. 41: 843-8. PMID 19483683 DOI: 10.1038/Ng.392 |
0.67 |
|
2008 |
Piskounova E, Viswanathan SR, Janas M, LaPierre RJ, Daley GQ, Sliz P, Gregory RI. Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. The Journal of Biological Chemistry. 283: 21310-4. PMID 18550544 DOI: 10.1074/Jbc.C800108200 |
0.472 |
|
2008 |
Lu CW, Yabuuchi A, Chen L, Viswanathan S, Kim K, Daley GQ. Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos. Nature Genetics. 40: 921-6. PMID 18536715 DOI: 10.1038/Ng.173 |
0.483 |
|
2008 |
Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science (New York, N.Y.). 320: 97-100. PMID 18292307 DOI: 10.1126/Science.1154040 |
0.479 |
|
Show low-probability matches. |